Staff Reporter
Islamabad
Pakistan has joined the list of those few countries with the technology to produce heart stents locally. Prime Minister Imran Khan inaugurated the N-Ovative Health Technology Facility at the National University of Science and Technology (NUST) today.
The PM Office said that the facility will be the first to locally manufacture cardiac stents, adding that it will also make Pakistan the 18th country in the world to do so.
PM Imran Kha addressing the inauguration ceremony of launching the first facility of producing stents in Pakistan, lashed out at the Opposition leaders for destroying Pakistan and said that it is easy for him to give “NRO” to them but it is the “path to destruction”.
“We have to make difficult decisions and difficult decisions to take us forward,” he said.
He said the country was “going in the right direction”, and that giving an NRO at this moment would be the easy way out from the difficulties he faces as premier.
“Many times in life, we have the choice of walking two different paths. We are encouraged to take the easy way out,” he said.
“You wake up in the morning and you have all the dacoits gathered up against you, and [you want to] go for the easy way and compromise,” he said, perhaps hinting at the political choices he faces these days. The “easy way” is to “forgive them all and give an NRO, ha added.
.“Our lives will also become easy. We will do speeches in parliament and three or four years will go by. But, this is the path to destruction,” he warned.He added that the path to betterment is never easy and people therefore have to make “difficult decisions” that, in the future, define them. Earlier in his address, PM Imran expressed his happiness and congratulated NUST on achieving the feat of producing locally made stents.
PM Imran said that in Pakistan and the world, “most people die due to heart diseases”, noting that it was an expensive treatment. He said the locally produced stents will benefit the country by saving foreign exchange (by preventing imports) as well as helping treat more poor patients as they will be cheaper in comparison.
